Literature DB >> 12377652

Influence of cigarette smoking on the presentation and course of acute myeloid leukemia.

Y Chelghoum1, C Danaïla, A Belhabri, C Charrin, Q-H Le, M Michallet, D Fiere, X Thomas.   

Abstract

BACKGROUND: It is known that cigarette smoking is associated with an approximately 50% increase in leukemia risk. In order to detect a possible influence of cigarette smoking on initial characteristics at the time of presentation and on the course of the disease, we conducted a retrospective study in 643 patients with newly diagnosed acute myeloid leukemia. PATIENTS AND METHODS: The study comprised 339 males and 304 females (median age 59 years, range 18-84 years). Two hundred and ninety-six patients (46%), smoking at least one cigarette per day for 6 months, were considered as smokers, while 347 patients (54%) were non-smokers.
RESULTS: Cigarette smoking was significantly related to male gender (P <0.0001), professional occupancy (P = 0.002), presence of organomegaly (P = 0.01), and lower peripheral blood and bone marrow leukemic cell involvement (P = 0.007 and P = 0.0001, respectively). Leukemia of French-American-British (FAB) M1 subtype was more frequent in non-smokers (P = 0.005). Although not statistically significant, smokers tended to have lower leukocyte counts than non-smokers. No difference was noted in terms of complete remission rates between smokers and non-smokers (67% compared to 64%). However, a higher rate of severe pulmonary infection was observed in smokers during induction chemotherapy (P = 0.02). Cigarette smoking (>or=20 pack-years or smoking duration >or=30 years) was significantly associated with shorter disease-free survival (P = 0.03) and overall survival (OS; P = 0.02 and P = 0.004, respectively). Other characteristics associated with poor prognosis included mainly older age, unfavorable karyotype, secondary acute myeloid leukemia (AML) and elevated World Health Organization (WHO) performance status. Cigarette smoking was associated with shorter OS in younger adults, but did not significantly influence survival in patients >60 years old. Cigarette smoking worsened the poor OS in patients with unfavorable karyotype, but did not significantly influence the prognosis of other karyotypic risk groups. In a multivariate analysis, only karyotypic grouping and age remained of prognostic value for the occurrence of disease-free and overall survival.
CONCLUSIONS: Cigarette smoking has a deleterious effect on survival in AML by shortening complete remission duration and subsequent survival. It was associated with severe infections during aplasia. Leukemogenic compounds favoring complex karyotypic abnormalities could also be involved.

Entities:  

Mesh:

Year:  2002        PMID: 12377652     DOI: 10.1093/annonc/mdf269

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  18 in total

1.  Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes.

Authors:  Xiaomei Ma; Rong Wang; Naomi Galili; Susan T Mayne; Sa A Wang; Herbert Yu; Azra Raza
Journal:  Cancer Causes Control       Date:  2011-02-02       Impact factor: 2.506

2.  Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

Authors:  Mohamed L Sorror; Sergio Giralt; Brenda M Sandmaier; Marcos De Lima; Munir Shahjahan; David G Maloney; H Joachim Deeg; Frederick R Appelbaum; Barry Storer; Rainer Storb
Journal:  Blood       Date:  2007-09-14       Impact factor: 22.113

3.  Tobacco smoking is associated with infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.

Authors:  R Hanajiri; K Kakihana; T Kobayashi; N Doki; H Sakamaki; K Ohashi
Journal:  Bone Marrow Transplant       Date:  2015-05-18       Impact factor: 5.483

4.  Socioeconomic status and lifestyle behaviours in cancer survivors: smoking and physical activity.

Authors:  H Naik; X Qiu; M C Brown; L Eng; D Pringle; M Mahler; H Hon; K Tiessen; H Thai; V Ho; C Gonos; R Charow; V Pat; M Irwin; L Herzog; A Ho; W Xu; J M Jones; D Howell; G Liu
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

Review 5.  The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Authors:  Uwe A Wittel; Navneet Momi; Gabriel Seifert; Thorsten Wiech; Ulrich T Hopt; Surinder K Batra
Journal:  Int J Oncol       Date:  2012-03-23       Impact factor: 5.650

6.  Parental Tobacco Smoking and Acute Myeloid Leukemia: The Childhood Leukemia International Consortium.

Authors:  Catherine Metayer; Eleni Petridou; Juan Manuel Mejía Aranguré; Eve Roman; Joachim Schüz; Corrado Magnani; Ana Maria Mora; Beth A Mueller; Maria S Pombo de Oliveira; John D Dockerty; Kathryn McCauley; Tracy Lightfoot; Emmanouel Hatzipantelis; Jérémie Rudant; Janet Flores-Lujano; Peter Kaatsch; Lucia Miligi; Catharina Wesseling; David R Doody; Maria Moschovi; Laurent Orsi; Stefano Mattioli; Steve Selvin; Alice Y Kang; Jacqueline Clavel
Journal:  Am J Epidemiol       Date:  2016-08-03       Impact factor: 4.897

7.  Perceptions of Continued Smoking and Smoking Cessation Among Patients With Cancer.

Authors:  Devon Alton; Lawson Eng; Lin Lu; Yuyao Song; Jie Su; Delaram Farzanfar; Rahul Mohan; Olivia Krys; Katie Mattina; Christopher Harper; Sophia Liu; Tom Yoannidis; Robin Milne; M Catherine Brown; Ashlee Vennettilli; Andrew J Hope; Doris Howell; Jennifer M Jones; Peter Selby; Wei Xu; David P Goldstein; Geoffrey Liu; Meredith E Giuliani
Journal:  J Oncol Pract       Date:  2018-04-20       Impact factor: 3.840

8.  Correlates of continued smoking versus cessation among survivors of smoking-related cancers.

Authors:  Carla J Berg; Akilah N Thomas; Ann C Mertens; Gillian L Schauer; Erika A Pinsker; Jasjit S Ahluwalia; Fadlo R Khuri
Journal:  Psychooncology       Date:  2012-04-09       Impact factor: 3.894

Review 9.  Tobacco use and cessation for cancer survivors: an overview for clinicians.

Authors:  Maher Karam-Hage; Paul M Cinciripini; Ellen R Gritz
Journal:  CA Cancer J Clin       Date:  2014-05-09       Impact factor: 508.702

10.  Harm reduction and cessation efforts and interest in cessation resources among survivors of smoking-related cancers.

Authors:  Carla J Berg; Matthew J Carpenter; Bianca Jardin; Jamie S Ostroff
Journal:  J Cancer Surviv       Date:  2013-01-10       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.